UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002251
Receipt number R000002756
Scientific Title preliminary study of the efficacy of 5ALA on prostate cancer
Date of disclosure of the study information 2009/08/01
Last modified on 2017/08/04 12:46:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

preliminary study of the efficacy of 5ALA on prostate cancer

Acronym

preliminary study of the efficacy of 5ALA on prostate cancer

Scientific Title

preliminary study of the efficacy of 5ALA on prostate cancer

Scientific Title:Acronym

preliminary study of the efficacy of 5ALA on prostate cancer

Region

Japan


Condition

Condition

prostate cancer

Classification by specialty

Urology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The patient,who will be performed radical prostatectomy,intake 5ALA before the operation,we observe prostate cancer,which produce fluorescence or not,through the fluorescent endoscopy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the existence or nonexistence of fluorescence in tumor

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine

Interventions/Control_1

5ALA oral intake

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

none

Key exclusion criteria

photo-sensitive patients

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Isao KURODA

Organization

Saitama Medical University,International Medical Center

Division name

Uro-oncology

Zip code


Address

1397-1,Yamane,Hidaka,Saitama,Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Isao KURODA

Organization

Saitama Medical University,International Medical Center

Division name

Uro-oncology

Zip code


Address

1397-1,Yamane,Hidaka,Saitama,Japan

TEL


Homepage URL


Email



Sponsor or person

Institute

Saitama Medical University,International Medical Center
Department of Uro-oncology

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University,International Medical Center
Department of Uro-oncology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 07 Month 31 Day

Date of IRB


Anticipated trial start date

2009 Year 08 Month 01 Day

Last follow-up date

2011 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 07 Month 26 Day

Last modified on

2017 Year 08 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002756


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name